{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:29:38Z","timestamp":1779204578847,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["No. ZR2017MH055"],"award-info":[{"award-number":["No. ZR2017MH055"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81900824"],"award-info":[{"award-number":["No. 81900824"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the \u201cClinical Medicine + X\u201d Engineering Research Project of Qingdao University Medical College"},{"name":"the Young Investigator Fund of Affiliated Hospital, Qingdao University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s10792-021-01703-6","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T12:04:54Z","timestamp":1612440294000},"page":"1635-1642","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Evaluation of vitrectomy\u00a0combined preoperative intravitreal ranibizumab and postoperative intravitreal triamcinolone acetonide for proliferative diabetic retinopathy"],"prefix":"10.1007","volume":"41","author":[{"given":"Liting","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiulu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3339-562X","authenticated-orcid":false,"given":"Zhaodong","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiqiu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,4]]},"reference":[{"issue":"10","key":"1703_CR1","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.2337\/diacare.27.10.2540","volume":"27","author":"DS Fong","year":"2004","unstructured":"Fong DS, Aiello LP, Ferris FL 3rd, Klein R (2004) Diabetic retinopathy. Diabetes Care 27(10):2540\u20132553","journal-title":"Diabetes Care"},{"issue":"4","key":"1703_CR2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/ceo.12752","volume":"44","author":"T Sharma","year":"2016","unstructured":"Sharma T, Fong A, Lai TY, Lee V, Das S, Lam D (2016) Surgical treatment for diabetic vitreoretinal diseases: a review. Clin Exp Ophthalmol 44(4):340\u2013354","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"1703_CR3","first-page":"171","volume":"30","author":"G Guan","year":"2015","unstructured":"Guan G, Zang J (2015) Meta-analysis of the effect of perioperative injection of Lucentis on intraoperative bleeding in patients with proliferative diabetic retinopathy. Eye Sci 30(4):171\u2013175","journal-title":"Eye Sci"},{"issue":"6","key":"1703_CR4","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1177\/112067211002000604","volume":"20","author":"SE Hernandez-Da Mota","year":"2010","unstructured":"Hernandez-Da Mota SE, Nunez-Solorio SM (2010) Experience with intravitreal bevacizumab as a preoperative adjunct in 23-G vitrectomy for advanced proliferative diabetic retinopathy. Eur J Ophthalmol 20(6):1047\u20131052","journal-title":"Eur J Ophthalmol"},{"issue":"9","key":"1703_CR5","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1136\/bjo.2010.189514","volume":"95","author":"LQ Zhao","year":"2011","unstructured":"Zhao LQ, Zhu H, Zhao PQ, Hu YQ (2011) A systematic review and meta-analysis of clinical outcomes of vitrectomy with or without intravitreal bevacizumab pretreatment for severe diabetic retinopathy. Br J Ophthalmol 95(9):1216\u20131222","journal-title":"Br J Ophthalmol"},{"key":"1703_CR6","first-page":"971758","volume":"2013","author":"V Romano","year":"2013","unstructured":"Romano V, Angi M, Scotti F, del Grosso R, Romano D, Semeraro F, Vinciguerra P, Costagliola C, Romano MR (2013) Inflammation and macular oedema after pars plana vitrectomy. Mediators Inflamm 2013:971758","journal-title":"Mediators Inflamm"},{"issue":"5","key":"1703_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4239\/wjd.v4.i5.165","volume":"4","author":"P Romero-Aroca","year":"2013","unstructured":"Romero-Aroca P (2013) Current status in diabetic macular edema treatments. World J Diabetes 4(5):165\u2013169","journal-title":"World J Diabetes"},{"key":"1703_CR8","first-page":"825","volume":"8","author":"S Nonomura","year":"2014","unstructured":"Nonomura S, Oshitari T, Arai M, Sato E, Takatsuna Y, Baba T, Yamamoto S (2014) The effect of posterior sub-Tenon\u2019s capsule triamcinolone acetonide injection to that of pars plana vitrectomy for diabetic macular edema. Clin Ophthalmol 8:825\u2013830","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"1703_CR9","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1089\/jop.2006.22.200","volume":"22","author":"JB Jonas","year":"2006","unstructured":"Jonas JB, Kamppeter BA, Harder B, Vossmerbaeumer U, Sauder G, Spandau UH (2006) Intravitreal triamcinolone acetonide for diabetic macular edema: a prospective, randomized study. J Ocul Pharmacol Ther 22(3):200\u2013207","journal-title":"J Ocul Pharmacol Ther"},{"issue":"9","key":"1703_CR10","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.ophtha.2006.02.065","volume":"113","author":"MC Gillies","year":"2006","unstructured":"Gillies MC, Sutter FK, Simpson JM, Larsson J, Ali H, Zhu M (2006) Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 113(9):1533\u20131538","journal-title":"Ophthalmology"},{"issue":"2","key":"1703_CR11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000331935","volume":"227","author":"JW Lim","year":"2012","unstructured":"Lim JW, Lee HK, Shin MC (2012) Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial. Ophthalmologica 227(2):100\u2013106","journal-title":"Ophthalmologica"},{"issue":"4","key":"1703_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1177\/1060028014568006","volume":"49","author":"E Jin","year":"2015","unstructured":"Jin E, Luo L, Bai Y, Zhao M (2015) Comparative effectiveness of intravitreal bevacizumab with or without triamcinolone acetonide for treatment of diabetic macular edema. Ann Pharmacother 49(4):387\u2013397","journal-title":"Ann Pharmacother"},{"issue":"4","key":"1703_CR13","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00417-007-0688-0","volume":"246","author":"H Ahmadieh","year":"2008","unstructured":"Ahmadieh H, Ramezani A, Shoeibi N, Bijanzadeh B, Tabatabaei A, Azarmina M, Soheilian M, Keshavarzi G, Mohebbi MR (2008) Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial. Graefes Arch Clin Exp Ophthalmol 246(4):483\u2013489","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"1703_CR14","first-page":"352","volume":"124","author":"YS Wang","year":"2011","unstructured":"Wang YS, Li X, Wang HY, Zhang ZF, Li MH, Su XN (2011) Intravitreal bevacizumab combined with\/without triamcinolone acetonide in single injection for treatment of diabetic macular edema. Chin Med J (Engl) 124(3):352\u2013358","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"1703_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000098253","volume":"221","author":"P Kroll","year":"2007","unstructured":"Kroll P, Rodrigues EB, Hoerle S (2007) Pathogenesis and classification of proliferative diabetic vitreoretinopathy. Ophthalmologica 221(2):78\u201394","journal-title":"Ophthalmologica"},{"issue":"2","key":"1703_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ajo.2008.04.028","volume":"146","author":"CM Yang","year":"2008","unstructured":"Yang CM, Yeh PT, Yang CH, Chen MS (2008) Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy. Am J Ophthalmol 146(2):211\u2013217","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"1703_CR17","doi-asserted-by":"publisher","first-page":"e14603","DOI":"10.1097\/MD.0000000000014603","volume":"98","author":"DF Sun","year":"2019","unstructured":"Sun DF, Wang YL, Wang B, Xu CL, Zhang G, Li J, Zhang XM (2019) Predictive risk factors for exudative retinal detachment after vitrectomy for proliferative diabetic retinopathy. Medicine (Baltimore) 98(8):e14603","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1703_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/IAE.0b013e3182979df6","volume":"34","author":"Y Suzuki","year":"2014","unstructured":"Suzuki Y, Suzuki K, Yokoi Y, Miyagawa Y, Metoki T, Nakazawa M (2014) Effects of intravitreal injection of bevacizumab on inflammatory cytokines in the vitreous with proliferative diabetic retinopathy. Retina 34(1):165\u2013171","journal-title":"Retina"},{"issue":"4","key":"1703_CR19","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0002-9394(14)75794-0","volume":"118","author":"AP Adamis","year":"1994","unstructured":"Adamis AP, Miller JW, Bernal MT, D\u2019Amico DJ, Folkman J, Yeo TK, Yeo KT (1994) Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118(4):445\u2013450","journal-title":"Am J Ophthalmol"},{"issue":"22","key":"1703_CR20","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","volume":"331","author":"LP Aiello","year":"1994","unstructured":"Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331(22):1480\u20131487","journal-title":"N Engl J Med"},{"issue":"6","key":"1703_CR21","first-page":"638","volume":"72","author":"J Pe'er","year":"1995","unstructured":"Pe\u2019er J, Shweiki D, Itin A, Hemo I, Gnessin H, Keshet E (1995) Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest 72(6):638\u2013645","journal-title":"Lab Invest"},{"key":"1703_CR22","first-page":"4927259","volume":"2018","author":"J Cui","year":"2018","unstructured":"Cui J, Chen H, Lu H, Dong F, Wei D, Jiao Y, Charles S, Gu W, Wang L (2018) Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy. J Ophthalmol 2018:4927259","journal-title":"J Ophthalmol"},{"issue":"6","key":"1703_CR23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1001\/jama.2010.1111","volume":"304","author":"X Zhang","year":"2010","unstructured":"Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, Gregg EW, Albright AL, Klein BE, Klein R (2010) Prevalence of diabetic retinopathy in the United States, 2005\u20132008. JAMA 304(6):649\u2013656","journal-title":"JAMA"},{"issue":"6","key":"1703_CR24","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00417-002-0454-2","volume":"240","author":"T Sakamoto","year":"2002","unstructured":"Sakamoto T, Miyazaki M, Hisatomi T, Nakamura T, Ueno A, Itaya K, Ishibashi T (2002) Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol 240(6):423\u2013429","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"1703_CR25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1006\/jsre.2002.6415","volume":"104","author":"TR Desai","year":"2002","unstructured":"Desai TR, Leeper NJ, Hynes KL, Gewertz BL (2002) Interleukin-6 causes endothelial barrier dysfunction via the protein kinase C pathway. J Surg Res 104(2):118\u2013123","journal-title":"J Surg Res"},{"issue":"2","key":"1703_CR26","first-page":"710","volume":"131","author":"N Maruo","year":"1992","unstructured":"Maruo N, Morita I, Shirao M, Murota S (1992) IL-6 increases endothelial permeability in vitro. Endocrinology 131(2):710\u2013714","journal-title":"Endocrinology"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-01703-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-021-01703-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-01703-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T14:35:18Z","timestamp":1619793318000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-021-01703-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,4]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1703"],"URL":"https:\/\/doi.org\/10.1007\/s10792-021-01703-6","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,4]]},"assertion":[{"value":"25 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The datasets used and\/or analyzed during the current study are available from the corresponding author upon reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"This study followed the tenets of the Declaration of Helsinki and was approved by the Ethics Committee, Affiliated Hospital of Qingdao University. All patients provided written consent to participate in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This study followed the tenets of the Declaration of Helsinki and was approved by the Ethics Committee, Affiliated Hospital of Qingdao University. All patients provided written consent to participate in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}